Skip to main content

Advertisement

Log in

Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract.

Brain tissue from 44 patients with Parkinson's disease (PD) and 36 age-matched controls was examined for choline acetyltransferase (ChAT) activity, and for densities of D1 and D2 dopamine receptors. Brain samples were examined for Alzheimer' disease (AD) type changes and for Lewy bodies (LBs), and for apolipoprotein E genotype. Patients were evaluated for the stage of cognitive impairment using Reisberg's global deterioration scale. ChAT activity in PD was reduced in all brain areas examined, being 51% of the control mean in the hippocampus (P<0.001), 57% in the prefrontal cortex (P<0.001) and 64% in the temporal cortex (P<0.001). The number of LBs had a significant negative correlation with ChAT activity in both prefrontal (r=–0.33, P<0.05) and temporal cortex (r=–0.32, P<0.05). The reduction in ChAT activity in the prefrontal cortex had a significant negative correlation (r=–0.38, P=0.012) with the extent of cognitive impairment. When the CERAD class 'C' was excluded, cognitive impairment correlated significantly with both prefrontal ChAT activity (r=–0.52, P=0.0051) and the density of D1 dopamine receptors in the caudate nucleus (r=–0.40, P=0.037). The number of D1 and D2 dopamine receptors was reduced in both caudate nucleus and putamen in PD patients without neuroleptics as compared to controls. An increased D2 receptor number was found in the caudate nucleus and putamen in PD patients treated with neuroleptics. The present study showed that cognitive decline in PD is associated with reduced ChAT activity in the prefrontal cortex and the D1 dopamine receptor number in the caudate nucleus, even in the absence of AD-type pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Revised accepted: 22 January 2001

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mattila, P.M., Röyttä, M., Lönnberg, P. et al. Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol 102, 160–166 (2001). https://doi.org/10.1007/s004010100372

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004010100372

Navigation